Ten stocks boasted whopping gains on Thursday, outperforming Wall Street’s main indices, as investors took heart from a flurry of analyst ratings and corporate developments. Of the 10 firms, five notably jumped to new record highs.

Meanwhile, Wall Street’s main indices all finished in the green, led by the Dow Jones with 0.60 percent gains, followed by the S&P 500 with 0.26 percent, and the Nasdaq with 0.25 percent.

Indices aside, this article names the 10 top-performing stocks on Thursday and details the reasons behind their gains.

To come up with the list, we focused exclusively on stocks with more than $2 billion in market capitalization and 5 million shares in trading volume.

10. CompoSecure Inc. (NYSE:CMPO)

CompoSecure extended its winning streak to a third straight day on Thursday, jumping 7.86 percent to close at $25.25 apiece as investors took heart from an initiative to reduce its existing debt, while digesting the impact of its rebranding.

In a statement, CompoSecure Inc. (NYSE:CMPO) said that it was able to reduce its existing old debt following the successful raising of some $2.5 billion in fresh funds from the issuance of $900 million worth of senior secured notes due 2033, a new term loan facility amounting to $1.2 billion, and $400 million in revolving commitments due 2031.

The notes carry a yield rate of 5.625 percent per annum, payable semi-annually on February 1 and August 1 of each year until their maturity.

Meanwhile, the term loan carries an interest rate based on the standard overnight financing rate plus 2.25 percent, and was issued at a price of 99.875 percent of the face amount.

“This refinancing lowers the company’s overall cost of capital, extends maturities, and enhances liquidity and financial flexibility, strengthening the Company’s capital structure to support continued strategic growth initiatives,” CompoSecure Inc. (NYSE:CMPO) said.

Meanwhile, CompoSecure Inc. (NYSE:CMPO) on Monday announced plans to rebrand to GPGI Inc., which means “Great Positions in Good Industries.” Its ticker symbol would also change to GPGI from CMPO beginning January 23, 2026.

The rebrand followed the successful merger with Husky Technologies Ltd. valuing the merged firm at $7.4 billion.

9. Entegris Inc. (NASDAQ:ENTG)

Entegris rallied for a third straight day on Thursday to hit a new 52-week high as investors gobbled up shares ahead of an upcoming dividend, while also taking path from an analyst’s 61 percent price target hike for its stock.

At intra-day trading, Entegris Inc. (NASDAQ:ENTG) climbed to as high as $118 before trimming gains to finish the session just up by 9.08 percent at $113.54 apiece.

This followed a market report from UBS on the same day, issuing a “buy” recommendation on the stock after being neutral previously, while upgrading its price target to $145 from $90. The figure marked a 27.7 percent upside from its latest closing price.

According to UBS, the revision was based on its optimism that Entegris Inc. (NASDAQ:ENTG) would benefit from a broader MSI system recovery, Taiwan Semiconductor’s expansion of N2 nodes production, and the broader adoption of molybdenum, among others.

UBS expects the said factors to contribute to a projected revenue growth of 10 percent and 11 percent in 2026 and 2027, respectively.

In other news, Entegris Inc. (NASDAQ:ENTG) said that it would provide $0.10 in quarterly cash dividends to all shareholders as of January 28, payable on February 18, 2026.

8. Alphatec Holdings Inc. (NASDAQ:ATEC)

Alphatec Holdings snapped a four-day losing streak on Thursday, jumping 9.47 percent to close at $17.46 apiece as investors resorted to bargain-hunting after falling to a two-month low while digesting the preliminary results of its earnings performance last year.

Earlier this week, Alphatec Holdings Inc. (NASDAQ:ATEC) said that it is expecting to report total revenues between $763.4 million and $764.4 million for full-year 2025, or an implied growth of 25 percent and higher than its previous guidance of $760 million.

The bulk of the revenues—amounting to $686.3 million to $687 million—is expected to come from surgical revenues, while the remaining $77.1 million to $77.4 million would come from EOS revenues.

“We are achieving results at scale that have not been seen in our industry. This shared success is no accident; we have amassed an unparalleled collection of spine know-how and clinical curiosity, and are relentlessly driven to improve surgery through a disciplined focus on procedural ecosystems, supported by data and informatics. We have many growth catalysts ahead, and with a scalable infrastructure already in place, ATEC is positioned to shape the future of spine care for years to come,” said Alphatec Holdings Inc. (NASDAQ:ATEC) Chairman and CEO Pat Miles.

For 2026, the company is gunning for revenues of $890 million, or an implied growth of 17 percent from 2025. The outlook includes its target of $805 million from surgical revenues and approximately $85 million from EOS.

7. StubHub Holdings Inc. (NYSE:STUB)

StubHub Holdings extended its winning streak to a third day on Thursday, surging 11.36 percent to close at $15.20 apiece despite the lack of positive developments to boost buying appetite, while shunning revived notices to serve as plaintiff in a recent class action lawsuit filed versus the company.

On the same day, nearly 20 shareholder law firms reminded investors to reach out ahead of the looming January 23 deadline to lead as a plaintiff in a lawsuit against StubHub Holdings Inc. (NYSE:STUB), allegedly for misrepresenting in its registration statement its business, operations, and prospects.

According to the lawsuit, StubHub Holdings Inc. (NYSE:STUB) failed to disclose that it was experiencing changes in the timing of payments to vendors and that the changes had a significant adverse impact on its free cash flow.

Founded in 2000, StubHub Holdings, Inc. (NYSE:STUB) is a newly listed company on the New York Stock Exchange, having only debuted on September 17, 2025. It is engaged in the business of offering a marketplace platform where people can buy and sell tickets online for live events.

During its initial public offering, the company was able to raise $800 million, having issued more than 34 million shares to the public.

6. Penumbra Inc. (NYSE:PEN)

Penumbra soared to a new all-time high on Thursday, as investors snapped up shares following announcements that it is set to be acquired by Boston Scientific Corporation for $14.5 billion.

At intra-day trading, the stock surged to its highest price of $352.15 before trimming gains to finish the session just up by 11.82 percent at $350.49 apiece.

This followed announcements from Boston Scientific that it entered into a definitive agreement to acquire Penumbra Inc. (NYSE:PEN) at $374 apiece in a combination of cash and stock transaction.

Under the agreement, Penumbra Inc. (NYSE:PEN) shareholders have the right to choose to be paid $374 in cash or 3.8721 shares of Boston Scientific common stock for every PEN share they own.

The transaction is expected to be completed in 2026, subject to the receipt of other regulatory approvals, including shareholders, as well as the satisfaction of other customary closing conditions.

Upon closing, Penumbra Inc.’s (NYSE:PEN) Chairman and CEO Adam Elsesser, would also join Boston Scientific’s board of directors.

“Penumbra is a well-established company with an experienced, high-performing team and this acquisition offers Boston Scientific an opportunity to enter new, fast-growing segments within the vascular space,” said Boston Scientific Chairman and CEO Mike Mahoney.

“The addition of Penumbra can expand access for these novel technologies to more patients and customers around the world, further enhancing our revenue and margins over time with proven offerings that have a history of growth and innovation,” he added.

5. Fluence Energy Inc. (NASDAQ:FLNC)

Fluence Energy climbed to a new two-year high on Thursday, as investors gobbled up shares ahead of the results of its first quarter earnings performance for the first quarter of fiscal year 2026, alongside announcements of a newly-bagged supply deal.

At intra-day trading, the stock climbed to its highest price of $26.32 before paring gains to finish the session just up by 12.58 percent at $25.50 apiece.

This followed announcements on the same day that it would release the official results of its financial and operating highlights for the past quarter after market close on February 4, 2026, a Wednesday.

Fluence Energy Inc. (NASDAQ:FLNC) will hold a conference call at 8:30 AM EST on February 5, a Thursday, to detail the results.

In other news, Fluence Energy Inc. (NASDAQ:FLNC) said that it inked a long-term agreement with BrightNight and Cordelio Power for the supply of its Gridstack Pro energy storage solutions for their Pioneer Clean Energy Center joint venture project in Yuma County, Arizona.

The said project features a 300 MW AC solar facility with a 300 MW/1,200 MWh battery energy storage system. The facility is expected to provide firm, on-demand capacity for Arizona’s electricity needs.

The Gridstack Pro solution will incorporate US-manufactured cells, modules, enclosures, and thermal management systems, supporting the advancement of domestically produced energy storage technology while strengthening American energy security.

“We first put storage on the US grid to meet exactly the kind of reliability needs Arizona is facing, and we have since proven that it can be delivered at massive scale,” Fluence Energy Inc. (NASDAQ:FLNC) Chief Customer Success Officer John Zahurancik said.

4. Galaxy Digital (NASDAQ:GLXY)

Galaxy Digital rallied for a fourth consecutive day on Thursday, jumping 13.48 percent to close at $31.99 apiece as investors loaded portfolios after securing approval to build another 830 MW data center in West Texas, while increasing positions ahead of the results of its earnings performance.

According to the company, it secured the approval of the Electric Reliability Council of Texas for an additional 830 MW of computing demand at its Helios data center, bringing the facility’s total approved capacity to 1.6 GW. The approval followed the completion of a Large Load Interconnection Study, which was facilitated by Wind Energy Transmission Texas, and which would also serve as the transmission interconnection provider.

In line with the approval, Galaxy Digital (NASDAQ:GLXY) clinched a service agreement with AEP Texas Inc. to support the expansion.

“This new 830 MW approval represents a major step forward in Helios’s long-term development, effectively doubling the campus’s approved power capacity and supporting multi-tenant partnerships,” Galaxy Digital (NASDAQ:GLXY) said.

It added that while the Helios data center is still under construction, it remains on track to deliver its initial power to CoreWeave—one of its major clients—in early 2026.

The company is also evaluating additional power and land opportunities within and beyond Texas.

Galaxy Digital (NASDAQ:GLXY) is set to announce its financial and operating highlights before market open on February 3, 2026, a Tuesday. A conference call will be held at 8:30 AM EST to elaborate on the results.

3. Erasca Inc. (NASDAQ:ERAS)

Erasca notched another three-year high anew on Thursday, as investor sentiment continued to be fueled by four investment firms’ bullish outlooks for its stock, with the company earning a price target upgrade of as much as 267 percent.

At intra-day trading, Erasca Inc. (NASDAQ:ERAS) touched a new record high of $9.72 before trimming a few cents to finish the session just up by 15.04 percent at $9.56 apiece.

The rally followed a flurry of positive coverage from Clear Street, HC Wainwright, Piper Sandler, and Stifel, with the said analysts issuing “buy” and “overweight” ratings for the stock.

Among the four, Clear Street became the most bullish, raising its price target by 267 percent to $11 from $3 previously, while maintaining a “buy” recommendation.

Meanwhile, HC Wainwright also gave a price target of $11 versus $6 previously, with a “buy” recommendation, following Erasca Inc.’s (NASDAQ:ERAS) positive preliminary results from the clinical study of its pan-RAS molecular glue degrader ERAS-0015. The topline results are scheduled to be released in the first half of 2026.

Earlier this month, Erasca Inc. (NASDAQ:ERAS) also received a $10 price target from Stifel, higher than the $6 previously, with the investment firm maintaining a “buy” recommendation.

Piper Sandler, for its part, initiated coverage for the company with an “overweight” rating but gave a much lower price target of just $5.

2. Figure Technology Solutions Inc. (NASDAQ:FIGR)

Figure Technology climbed to a new all-time high on Thursday, as investors took heart from Piper Sandler’s 36 percent price target hike for its stock.

At intra-day trading, Figure Technology Solutions Inc. (NASDAQ:FIGR) surged to its highest price of $64.98 before trimming 2 cents to end the day up by 16.37 percent at $64.96 apiece.

In a market report, Piper Sandler raised its price target for Figure Technology Solutions Inc. (NASDAQ:FIGR) to $75 from $55 previously, while maintaining an “overweight” rating after reporting a 133.6 percent expansion in consumer loan marketplace volume in the fourth quarter of 2025, beating Piper Sandler’s projection by 20 percent.

Following the results, Piper Sandler raised its earnings per share estimate for the company by 34 percent in the fourth quarter of the year, and by 18 percent for the years 2026 and 2027.

In other news, Figure Technology Solutions Inc. (NASDAQ:FIGR) officially launched the On-Chain Public Equity Network, which allows companies to list their equity native on blockchain.

Unlike other tokenization efforts, OPEN equities are blockchain-registered, not a tokenized version of Depository Trust and Clearing Corporation securities. The equities will trade on a limit order book using Figure’s Alternative Trading System, opening the door for continuous trading. Shareholders will be able to use Figure’s Democratized Prime, a decentralized finance protocol to borrow against and lend out their stock, disintermediating the role prime brokers traditionally play.

1. ImmunityBio Inc. (NASDAQ:IBRX)

ImmunityBio extended its winning streak to a 10^th consecutive day on Thursday, soaring 30.79 percent to close at $3.95 apiece, as investors loaded portfolios after achieving a 700 percent jump in preliminary revenues from Anktiva for the full-year 2025.

During the period, ImmunityBio Inc. (NASDAQ:IBRX) said that it registered $113 million in revenues from Anktiva amid strong demand. Anktiva is the first FDA-approved immunotherapy for non-muscle invasive bladder cancer.

In the fourth quarter alone, ImmunityBio Inc. (NASDAQ:IBRX) posted $38.3 million in net revenues, marking a 431 percent increase from the same period last year.

“ImmunityBio continues to see increased sales momentum supporting a trend of increases quarter-over-quarter with a 54 percent quarter over quarter unit volume growth rate during FY 2025,” it said.

In other recent news, ImmunityBio Inc. (NASDAQ:IBRX) has secured the approval of the Saudi Food and Drug Administration to sell and market Anktiva, in combination with an immune checkpoint inhibitor, in Saudi Arabia.

“This approval represents a significant step forward for lung cancer patients in the Kingdom of Saudi Arabia and a meaningful milestone that we hope will pave the way toward additional approvals across a region where lung cancer claims far too many lives each year,” said Executive Chairman Patrick Soon-Shiong.

While we acknowledge the potential of IBRX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than IBRX and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge fund investor letters by entering your email below.